Navigation Links
Chugai Pharmaceutical To Initiate Domestic Production Of Bird Flu Vaccine

A new project to manage the potential shortage of bird flu vaccine (Tamiflu) in Japan, the World’s biggest user of the anti-flu preparation, would soon be initiated by Chugai Pharmaceutical Company, a subsidiary of Roche Ltd. // Request by the Ministry of Health, Labor and Welfare of Japan is said to have sparked the initiative.

The domestic production of the bird flu vaccine is hoped to being in the next two years. The Swiss based F. Hoffmann-La Roche Ltd holds excusive rights to the bird flu vaccine production. The vaccine is even said to active against the latest versions of the avian influenza virus.

The company would initially produce syrup type preparation of Tamiflu, meant for children. Presently, the drug company is involved in packaging and sales of the anti-bird flu drug following production at the Swiss unit. Prior to this, the key ingredients of the drug are approved by Germany. Domestic production of drug is hoped to reduce the associated cost by a significant margin.

After a careful analysis of the profitability, the company would further decide regarding manufacture of the bird flu drug in a capsule form. There is a fear that rapid spread of a bird flu epidemic could lead to a shortage of bird flu vaccine supply. In order to increase preparedness against bird flu during the current bird flu season, the company has already acquired sufficient supplies to treat more than 12 million people.


'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. Pharmaceutical companies are targeting patients
5. FDA approves Watson Pharmaceuticals Oxytrol patch
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
8. Pharmaceutical industries grant for R&D to be monitored
9. Japanese And Chinese Pharmaceutical Companies Join Together In Drug Testing
10. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology: